Stockscreener 앱 받기
44.81
4.35%
-2.04
전일 마감가:
$46.85
열려 있는:
$45.805
하루 거래량:
1.82M
Relative Volume:
0.83
시가총액:
$5.95B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-10.57
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
-6.63%
1개월 성능:
+10.42%
6개월 성능:
+90.52%
1년 성능:
+137.34%
1일 변동 폭
$43.21
$46.18
1주일 범위
$43.21
$52.92
52주 변동 폭
$18.01
$52.92
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
44.83 | 5.95B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
423.61 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.04 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
478.45 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.11 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.81 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Guardant Health (GH): Scotiabank Raises Price Target to $57.00 | GH Stock News - GuruFocus
Genomic Cancer Testing Market Grows with Advances in Precision - openPR.com
Scotiabank Increases Guardant Health (GH) Price Target After Strong Q1 Performance | GH Stock News - GuruFocus
Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17 - Yahoo Finance
Decoding Guardant Health Inc (GH): A Strategic SWOT Insight - GuruFocus
Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue - Barchart.com
Guardant Health, Inc. (NASDAQ:GH) Q1 2025 Earnings Call Transcript - Insider Monkey
Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating - marketscreener.com
Guardant Health (GH) Price Target Boosted by BTIG to $65 Amid St - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 By Investing.com - Investing.com India
Guardant Health Reports Strong Q1 Revenue Growth - TipRanks
Guardant Health (GH) Sees Target Price Raised by TD Securities | - GuruFocus
Canaccord raises Guardant Health target to $65, maintains Buy By Investing.com - Investing.com Canada
Guardant Health (GH) Sees Price Target Raised by Canaccord Genui - GuruFocus
Guardant Health: Tailwinds Are Beginning To Impact The Financials (NASDAQ:GH) - Seeking Alpha
Guardant Health (GH) Price Target Increased Amid Positive Moment - GuruFocus
Guardant Health (GH) Receives Price Target Boost from UBS | GH S - GuruFocus
Stifel Raises Price Target for Guardant Health (GH) to $60 | GH Stock News - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analy - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analyst | GH Stock News - GuruFocus
Guardant Health (GH) Receives Price Target Increase from UBS | G - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 - Investing.com
UBS Adjusts Guardant Health Price Target to $70 From $65, Maintains Buy Rating - marketscreener.com
Canaccord raises Guardant Health target to $65, maintains Buy - Investing.com
Canaccord Increases Guardant Health (GH) Price Target to $65 | G - GuruFocus
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Barclays Lifts Guardant Health (GH) Price Target Amid Business G - GuruFocus
Earnings call transcript: Guardant Health Q1 2025 beats EPS forecast, revenue rises - Investing.com Nigeria
Guardant Health Q1 Adjusted Loss Widen, Revenue Rises; 2025 Revenue Guidance Raised - marketscreener.com
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo
Guardant Health Surpasses Q1 2025 Revenue ExpectationsNews and Statistics - IndexBox
Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - BioSpace
Guardant Health up 4% on Q1 beats, 2025 guidance revenue raise - MSN
Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth - GuruFocus
Guardant Health, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:GH) - Seeking Alpha
Guardant Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Guardant Health stock jumps 6.9% on earnings beat, raised guidance By Investing.com - Investing.com Nigeria
Guardant Health Inc (GH) Q1 2025 Earnings: EPS Loss of $0.77 Bea - GuruFocus
Guardant Health (GH) Revises Growth Forecasts and Financial Outl - GuruFocus
Guardant Health (GH) Surpasses Revenue Expectations with Strong Q1 Performance | GH Stock News - GuruFocus
Guardant Health: Q1 Earnings Snapshot - San Francisco Chronicle
Guardant Health stock jumps 6.9% on earnings beat, raised guidance - Investing.com Australia
Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars - Yahoo Finance
Guardant Health earnings beat by $0.26, revenue topped estimates - Investing.com
Earnings Flash (GH) Guardant Health Posts Q1 Revenue $203.5M, vs. FactSet Est of $190.1M - marketscreener.com
[Latest] Global Multi Cancer Early Detection Market Size/Share Worth USD 5.09 Billion by 2034 at a 14.85% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Guardant Health’s blood test shows promise for early cancer detection - Investing.com
Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types - 01net
Guardant Health Presents Data Demonstrating Strong Performance o - GuruFocus
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):